Mouse Models of Neurodegenerative Diseases: Criteria and General Methodology

Abstract

The major symptom of Alzheimer's disease is rapidly progressing dementia, coinciding with the formation of amyloid and tau deposits in the central nervous system, and neuronal death. At present familial cases of dementias provide the most promising foundation for modelling neurodegeneration. We describe the mnemonic and other major behavioral symptoms of tauopathies, briefly outline the genetics underlying familiar cases and discuss the arising implications for modelling the disease in mostly transgenic mouse lines. We then depict to what degree the most recent mouse models replicate pathological and cognitive characteristics observed in patients.There is no universally valid behavioral test battery to evaluate mouse models. The selection of individual tests depends on the behavioral and/or memory system in focus, the type of a model and how well it replicates the pathology of a disease and the amount of control over the genetic background of the mouse model. However it is possible to provide guidelines and criteria for modelling the neurodegeneration, setting up the experiments and choosing relevant tests. One should not adopt a "one (trans)gene, one disease" interpretation, but should try to understand how the mouse genome copes with the protein expression of the transgene in question. Further, it is not possible to recommend some mouse models over others since each model is valuable within its own constraints, and the way experiments are performed often reflects the idiosyncratic reality of specific laboratories. Our purpose is to improve bridging molecular and behavioural approaches in translational research. AbstractThe major symptom of Alzheimer's disease is rapidly progressing dementia, coinciding with the formation of amyloid and tau deposits in the central nervous system, and neuronal death. At present familial cases of dementias provide the most promising foundation for modelling neurodegeneration. We describe the mnemonic and other major behavioral symptoms of tauopathies, briefly outline the genetics underlying familiar cases and discuss the arising implications for modelling the disease in mostly transgenic mouse lines. We then depict to what degree the most recent mouse models replicate pathological and cognitive characteristics observed in patients. There is no universally valid behavioral test battery to evaluate mouse models. The selection of individual tests depends on the behavioral and/or memory system in focus, the type of a model and how well it replicates the pathology of a disease and the amount of control over the genetic background of the mouse model. However it is possible to provide guidelines and criteria for modelling the neurodegeneration, setting up the experiments and choosing relevant tests. One should not adopt a -one (trans)gene, one disease‖ interpretation, but should try to understand how the mouse genome copes with the protein expression of the transgene in question. Further, it is not possible to recommend some mouse models over others since each model is valuab...

Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains

“…However, coexistent impairments in nonmnemonic behavioral domains produces confounding variables the physical performance of mice that consequently influence the interpretation of results obtained in a cognitive task (Janus and Welzl, 2010). Similar to clinical approaches that encourage use of multiple screens (Cullen et al, 2007), assessing multiple behavioral domains in AD-mouse models should identify a broader range of responses that differentiate the behavioral profile of a model from its control.…”

Peptides Derived from Neuronal Cell Cycle like Kinase 5 Activator p35, in Neurodegeneration; Pathology and Therapy

“…A large, diverse selection of model mice has been engineered for each neurodegenerative disorder [37,38]. Most mouse models are prepared by introducing mutant human genes responsible for specific phenotypes.…”

“…Most mouse models are prepared by introducing mutant human genes responsible for specific phenotypes. In AD, for example, transgenic bearing several known mutations of the APP pathway have been constructed which show a progression to AD resembling the phenotype in humans [38]. For the most part, most mouse models do mimic pathologies characterizing specific disorders.…”

“…Behavioral criteria (memory, cognition, etc. ), however, are difficult to duplicate in mice for many obvious reasons [37][38][39]. This raises the question as to whether such studies provide insight as to the nature and mechanisms of the human syndromes and may explain why clinical trials based on animal studies have been disappointing.…”

Generation and Disease Model Relevance of a Manganese Enhanced Magnetic Resonance Imaging-Based NOD/scid-IL-2Rγ c null Mouse Brain Atlas

“…As a result, these mice are used for studies of a broad range of human diseases covering the disciplines of oncology, hematology, infectious disease and regenerative medicine. In particular, our laboratories and others have pursued investigation of human immunodeficiency virus type one (HIV-1) pathobiology including the studies of viral reservoirs and direct tissue injuries including the lung and the central nervous system (CNS) (Janus and Welzl 2010; Trancikova et al 2011; Gorantla et al 2012). …”